Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03572374 |
Recruitment Status :
Recruiting
First Posted : June 28, 2018
Last Update Posted : December 8, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Breast Cancer | Other: TEAMWork App Other: Information Booklet | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 546 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | Breast Cancer and the Workforce: Talking to Employers and Medical Staff About Work (TEAMWork) |
Actual Study Start Date : | June 7, 2018 |
Estimated Primary Completion Date : | June 2023 |
Estimated Study Completion Date : | June 2023 |

Arm | Intervention/treatment |
---|---|
Experimental: TEAMWork App
The 2-pronged approach of the intervention is operationalized through 2 menus, 1 focused on interactions with the employer and the other with the clinic team. Each menu has a list of features from which participants can choose to learn about a particular topic. A "My notes" button allows participants to take notes directly on the app. These notes will not be available to the research team, such that participants may use the tool without concerns about privacy. The workplace accommodations menu includes sample videos using trained actors to demonstrate how to approach an employer to request accommodations. Additional features include suggestions for accommodations that may be helpful, templates for letters participants can use when requesting accommodations, links to relevant websites, information about legal protections, and contact information for lawyers and firms that provide pro bono assistance.
|
Other: TEAMWork App
The 2-pronged approach of the intervention is operationalized through 2 menus, 1 focused on interactions with the employer and the other with the clinic team. Each menu has a list of features from which participants can choose to learn about a particular topic. A "My notes" button allows participants to take notes directly on the app. These notes will not be available to the research team, such that participants may use the tool without concerns about privacy. The workplace accommodations menu includes sample videos using trained actors to demonstrate how to approach an employer to request accommodations. Additional features include suggestions for accommodations that may be helpful, templates for letters participants can use when requesting accommodations, links to relevant websites, information about legal protections, and contact information for lawyers and firms that provide pro bono assistance.
Other Name: Talking to Employers and Medical Staff About Work (TEAMWork) |
Active Comparator: Information Booklet (control)
Participants will receive a booklet that includes the information in the app that can practicably be converted to paper. These participants will not have access to the multimedia aspects of the intervention, such as the videos, but they will have all of the relevant information in the app described above, including suggestions for accommodations, written templates for letters, links to websites, information about legal protections, and contact information for pro bono legal assistance. The booklet will also contain information about chemotherapy, radiation therapy and surgery, recommendations for management of common symptoms, and advice for communicating with the clinic team. The information booklet will be provided entirely on paper, although participants may independently access websites recommended in the booklet. The booklet content will mirror the app with regard to cultural responsiveness and appropriateness for different job types and characteristics.
|
Other: Information Booklet
Participants in the control arm will receive a booklet that includes the information in the app that can practicably be converted to paper. These participants will not have access to the multimedia aspects of the intervention, such as the videos, but they will have all of the relevant information in the app described above, including suggestions for accommodations, written templates for letters, links to websites, information about legal protections, and contact information for pro bono legal assistance. The booklet will also contain information about chemotherapy, radiation therapy and surgery, recommendations for management of common symptoms, and advice for communicating with the clinic team. The information booklet will be provided entirely on paper, although participants may independently access websites recommended in the booklet. The booklet content will mirror the app with regard to cultural responsiveness and appropriateness for different job types and characteristics. |
- number of participants still employed [ Time Frame: 2 years ]Talking to Employers and Medical Staff About Work (TEAMWork) the mobile application (app) is designed to educate patients and improve their communication skills with their employers and their oncology providers, thereby increasing access to work accommodations and optimizing symptom control during treatment. By increasing patients" ability to work during treatment, we believe the app will help them retain their jobs.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Gender Based Eligibility: | Yes |
Gender Eligibility Description: | Breast cancer |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Patient Usability Testing Inclusion Criteria:
- History of a cancer diagnosis
- At least 18 years of age
- Male or Female
- The ability to give informed consent in English or Spanish
- Able to use and read a smartphone (iPhone or Android)
- Has a smartphone (iPhone or Android)
Community Usability Testing Inclusion Criteria:
- At least 18 years of age
- Male or Female
- The ability to give informed consent in English or Spanish
- Able to use and read a smartphone (iPhone or Android)
- Has a smartphone (iPhone or Android)
Focus Group and Interview Inclusion Criteria:
- Completed chemotherapy treatment for stage I-III breast cancer.
- Age 18 to 64 (inclusive)
- Female
- Paid employment (full time or part time) in the three months prior to diagnosis or at time of consent to MSK protocol #10-071 (PI: Blinder)
- The ability to give informed consent in English or Spanish
- Able to use and read a smartphone (iPhone or Android)
- Has a smartphone (iPhone or Android)
For Cohort 2:
- Participants was covered by Emergency Medicaid at the time of diagnosis and/or at any point during their treatment for breast cancer
RCT Inclusion Criteria:
-
Localized invasive breast cancer (not stage 0 or stage IV)
- If electronic medical record does not specify stage and patient is undergoing (neo)adjuvant chemotherapy, assume stage is I, II or III
- Planning to undergo or undergoing adjuvant or neoadjuvant chemotherapy
- Age 18 to 64 (inclusive)
- Female
- Employment statue of (full time or part time) (those who are on disability leave/medical leave, and other unique employment circumstances at the PI's dicretion are eligible)
- Language preference as English or Spanish
- Able to use and read a smartphone or tablet (e.g. iPad, iPhone or Android)
- Has access to a smartphone or tablet (e.g. iPad, iPhone or Android)
Exclusion Criteria:
RCT Exclusion Criteria:
- Stage 0 breast cancer (DCIS only)
- Stage IV (metastatic) breast cancer
- Recurrence with metastases of breast cancer
- Participants or family members who are participating in MSK IHCD studies related to social determinants of health

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03572374
Contact: Victoria Blinder, M.D., M.Sc. | 646-888-4808 | blinderv@mskcc.org | |
Contact: Francesca Gany, M.D., M.Sc. | 646-888-8054 |
United States, New Jersey | |
Memoral Sloan Kettering Basking Ridge (Consent and Follow-up) | Recruiting |
Basking Ridge, New Jersey, United States, 07920 | |
Contact: Victoria Blinder, M.D., M.Sc 646-888-4808 | |
Memorial Sloan Kettering Monmouth (Consent and Follow-up) | Recruiting |
Middletown, New Jersey, United States, 07748 | |
Contact: Victoria Blinder, MD, MSc 646-888-4808 | |
Memorial Sloan Kettering Bergen (Consent and Follow up) | Recruiting |
Montvale, New Jersey, United States, 07645 | |
Contact: Victoria Blinder, M.D., M.Sc. 646-888-4808 | |
United States, New York | |
Lincoln Medical and Mental Health Center | Recruiting |
Bronx, New York, United States, 10451 | |
Contact: Monica Muppidi, MD 718-579-5874 | |
Montefiore Medical Center | Recruiting |
Bronx, New York, United States, 10467 | |
Contact: Della Makower, MD 718-862-8840 | |
Memorial Sloan Kettering Westchester (Consent and Follow-up) | Recruiting |
Harrison, New York, United States, 10604 | |
Contact: Victoria Blinder, M.D., M.Sc 646-888-4808 | |
Memorial Sloan Kettering Cancer Center | Recruiting |
New York, New York, United States, 10065 | |
Contact: Victoria Blinder, M.D., M.Sc 646-888-4808 | |
Contact: Francesca Gany, M.D., M.Sc 646-888-8054 |
Principal Investigator: | Victoria Blinder, M.D., M.Sc. | Memorial Sloan Kettering Cancer Center |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Memorial Sloan Kettering Cancer Center |
ClinicalTrials.gov Identifier: | NCT03572374 |
Other Study ID Numbers: |
18-217 |
First Posted: | June 28, 2018 Key Record Dates |
Last Update Posted: | December 8, 2022 |
Last Verified: | December 2022 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Workforce Employers Talking to Employers and Medical Staff About Work (TEAMWork) 18-217 |
Breast Neoplasms Neoplasms by Site Neoplasms Breast Diseases Skin Diseases |